Skip to main content

PPI Attorneys Request MDL Coordination in Delaware Litigation

PPI Attorneys Request MDL Coordination in Delaware Litigation

PPI Attorneys Request MDL Coordination in Delaware Litigation

Introduction

Attorneys associated with PPI lawsuits filed a proposal in the Superior Court of the State of Delaware on June 11 seeking coordination between MDL and Delaware Litigation. With this order, the parties hope to avoid any duplicate discovery while proceeding with the federal multidistrict litigation (MDL).

The court order states, ‘’the court and the parties are mindful of the desire for the efficiencies to be gained through the non-duplication of discovery between the Delaware PPI Actions and discovery taking place in the other consolidated actions.’’ Both parties are required to make serious efforts to minimize duplicate motions.

More than 4,500 lawsuits against Nexium, Prilosec, and other heartburn drugs continue to be linked to claims of kidney malfunction. Lawsuits over PPIs are filed across the U.S., which are centralized as a part of multidistrict litigation (MDL No. 2789; In Re: Proton-Pump Inhibitor Products Liability Litigation [No. II]) in the District of New Jersey before Judge Claire C. Cecchi for coordinated discovery and pretrial proceedings.

Comments

Restricted HTML

  • Allowed HTML tags: <a href hreflang> <em> <strong> <cite> <blockquote cite> <code> <ul type> <ol start type> <li> <dl> <dt> <dd> <h2 id> <h3 id> <h4 id> <h5 id> <h6 id>
  • Lines and paragraphs break automatically.
  • Web page addresses and email addresses turn into links automatically.

Latest News

Cencora Directors Settle Opioid Oversight Case for $111M

Categories: Opioids

Cencora has agreed to pay $111.3 million to settle a shareholder lawsuit accusing the company’s directors of failing to prevent the unlawful distribution of opioids

Study Finds CPAP May Harm Low-Risk Sleep Apnea Patients

A new study has cast doubt on the long-standing belief that continuous positive airway pressure (CPAP) machines significantly reduce heart…

FDA Adds New Warnings on Long-Term Opioid Risks

Categories: Opioids

Federal regulators have raised concerns that many opioid medications were approved for prolonged use without sufficient clinical evidence confirming their safety.

✍️ FREE — 2,800 Pages Legal Process Outsourcing Trial!                 
No Contract. No Risk — Full Mass Tort + LPO Access, Free!

Only 10 Firms Accepted—Offer Ends August 31!